2017
DOI: 10.1165/rcmb.2016-0053oc
|View full text |Cite
|
Sign up to set email alerts
|

Mechanical Stress and Single Nucleotide Variants Regulate Alternative Splicing of the MYLK Gene

Abstract: The nonmuscle (nm) myosin light-chain kinase isoform (MLCK), encoded by the MYLK gene, is a vital participant in regulating vascular barrier responses to mechanical and inflammatory stimuli. We determined that MYLK is alternatively spliced, yielding functionally distinct nmMLCK splice variants including nmMLCK2, a splice variant highly expressed in vascular endothelial cells (EC) and associated with reduced EC barrier integrity. We demonstrated previously that the nmMLCK2 variant lacks exon 11, which encodes a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
22
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 21 publications
(24 citation statements)
references
References 56 publications
1
22
0
Order By: Relevance
“…We recently used a minigene approach to address mechanisms that potentially underlie the regulation of MYLK splicing (15) and demonstrated the functional role of SNPs in altering MYLK splicing (15). It is well known that pre-mRNA splicing occurs through the activity of the spliceosome comprised of the heterogeneous nuclear ribonucleoproteins (hnRNPs), small nuclear ribonucleoprotein particles, and other components of the splicing machinery (16).…”
Section: Clinical Relevancementioning
confidence: 99%
See 2 more Smart Citations
“…We recently used a minigene approach to address mechanisms that potentially underlie the regulation of MYLK splicing (15) and demonstrated the functional role of SNPs in altering MYLK splicing (15). It is well known that pre-mRNA splicing occurs through the activity of the spliceosome comprised of the heterogeneous nuclear ribonucleoproteins (hnRNPs), small nuclear ribonucleoprotein particles, and other components of the splicing machinery (16).…”
Section: Clinical Relevancementioning
confidence: 99%
“…The minigene construct was constructed as we recently reported (15). Site-directed mutagenesis was performed using the QuikChange II site-directed mutagenesis kit (Agilent Technologies).…”
Section: Minigene Construct and Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…Racial and ethnic differences in susceptibility to and mortality from ARDS (12)(13)(14)(15)(16) support the increasingly recognized role of genetic factors in ARDS susceptibility (17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27), and highlight the importance of identifying genetic biomarkers of ARDS susceptibility in atrisk individuals to further improve risk stratification (28). We have previously identified several novel genetic ARDS biomarkers and therapeutic targets, including NAMPT (nicotinamide phosphoribosyl transferase), which encodes for a Toll-like receptor 4-binding cytozyme (17,24), MYLK (encoding MLCK [myosin lightchain kinase]) (19,26,29), GADD45a (growth arrest and DNA damage-inducible gene) (30), and sphingosine 1-phosphate receptor 3 (25).…”
mentioning
confidence: 96%
“…c-Src or c-Abl) compared to nmMLCK2 which has exon 11 deleted via alternative splicing. 1 , 32 We recently demonstrated that ARDS-related stimuli drive alternative splicing that favors greater expression of nmMLCK2, and thus less regulation by barrier-restoring stimuli, such as S1P and HGF, and consequently persistent gap formation. 32…”
Section: Discussionmentioning
confidence: 99%